Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-40,436
Closed -$159K 40
2018
Q4
$159K Sell
40,436
-3,153
-7% -$13.5K 0.65% 73
2018
Q3
$199K Buy
+43,589
New +$208K 0.65% 78
2018
Q2
Sell
-10,585
Closed -$77K 86
2018
Q1
$77K Buy
+10,585
New +$72.8K 0.2% 110
2017
Q4
Sell
-46,142
Closed -$304K 120
2017
Q3
$304K Buy
46,142
+28,028
+155% +$174K 0.78% 35
2017
Q2
$99K Buy
+18,114
New +$103K 0.23% 129
2016
Q2
Sell
-31,349
Closed -$162K 283
2016
Q1
$162K Sell
31,349
-19,021
-38% -$87.5K 0.11% 151
2015
Q4
$225K Buy
+50,370
New +$246K 0.19% 93
2014
Q3
Sell
-18,428
Closed -$130K 192
2014
Q2
$130K Buy
+18,428
New +$136K 0.06% 210

Other funds holding ABEV

QCM Cayman's ABEV Position: Q1 2019 in Review

QCM Cayman sold out of Ambev (ABEV) in Q1 2019, closing a stake of 40,436 shares — an estimated $159K sold.

QCM Cayman first reported a position in ABEV in Q2 2014 and held it in 8 quarters. The position peaked at $304K in Q3 2017. 305 funds tracked by Wall St. Rank hold ABEV as of Q1 2019.

  • QCM Cayman reported no remaining Ambev position as of Q1 2019 after selling out during the quarter.
  • QCM Cayman sold 40,436 Ambev shares in Q1 2019, an estimated $159K.
  • QCM Cayman first reported a position in Ambev in Q2 2014 and held it in 8 quarters.
  • QCM Cayman's Ambev position peaked at $304K in Q3 2017.
  • 305 funds tracked by Wall St. Rank held Ambev as of Q1 2019.

Based on QCM Cayman's 13F filing for Q1 2019, filed 13 May 2019.